Skip New Acute Migraine Meds Ubrogepant and Lasmiditan

March 2020

You may see home med lists include ubrogepant (Ubrelvy) or lasmiditan (Reyvow), new oral meds for acute migraines in adults.

Ubrogepant blocks receptors of calcitonin gene-related peptide (CGRP)...a vasodilator and pain sensitizer that spikes during acute migraines.

It’s different than the injectable monoclonal antibody CGRP antagonists for PREVENTION...erenumab (Aimovig), fremanezumab (Ajovy), and galcanezumab (Emgality).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote